India’s daily Covid death count hit a new grim record with 4,205 deaths in the last 24 hours; 3,48,421 fresh cases have been added to the active caseload amid the battle against the second wave, which has raised global concern.
As per Union Health Ministry figures the number of total cases stand at 2,33,40,938, while 1,93,82,642 patients have been discharged in the last 24 hours.
Meanwhile, Bharat Biotech’s Covid-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur. The Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech’s application seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.